TCR2 Therapeutics Inc (NASDAQ:TCRR)

1.34
Delayed Data
As of 3:58pm ET
 +0.08 / +6.35%
Today’s Change
1.23
Today|||52-Week Range
5.51
-71.24%
Year-to-Date

Stock Price Forecast

The 8 analysts offering 12-month price forecasts for TCR2 Therapeutics Inc have a median target of 10.50, with a high estimate of 20.00 and a low estimate of 2.00. The median estimate represents a +683.58% increase from the last price of 1.34.

Analyst Recommendations

The current consensus among 8 polled investment analysts is to Buy stock in TCR2 Therapeutics Inc. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.74
Sales
$0.00
Reporting Date
Apr 03

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 6.33%
 
 
 
 
 
 
Growthannually -16.68%
 
 
 
 
 
 

Sales

Growthquarterly --
Growthannually --
 
 
 
 
 
 
Key to the earnings and sales forecast charts.